1
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities and Exchange Commission
Date of Report (Date of earliest event reported): May 1, 1998
HADCO CORPORATION
(Exact name of Registrant as specified in its charter)
12A MANOR PARKWAY, SALEM, NEW HAMPSHIRE
(Address of principal executive offices)
03079
(Zip Code)
(603) 898-8000
Registrant's telephone number, including area code
MASSACHUSETTS 033-95284 04-2393279
State or other jurisdiction (Commission (IRS Employer
of Incorporation File Number) Identification)
2
ITEM 5. OTHER EVENTS.
On May 1, 1998, Hadco Corporation (the "Company") issued
a press release, a copy of which is attached as Exhibit 99 to this Current
Report on Form 8-K.
On March 27, 1998, the Company received a written notice from legal
counsel for the Lemelson Medical, Education & Research Foundation Limited
Partnership (the "Lemelson Partnership"), alleging that the Company is
infringing certain patents held by the Lemelson Partnership and offering to
license such patents to the Company. The ultimate outcome of this matter is not
currently determinable, and there can be no assurance that the outcome of this
matter will not have a material adverse effect upon the Company's business,
financial condition and results of operations. Litigation with respect to
patents and other intellectual property matters can result in substantial
damages, require the cessation of the manufacture, use and sale of infringing
products and the use of certain processes, or require the infringing party to
obtain a license to the relevant intellectual property.
On January 12, 1998, Hadco Santa Clara, Inc. (formerly Zycon Corporation)
received notice of the filing of a lawsuit, before the Superior Court (County
of Santa Clara, California), against it by Jackie Riley, Keith Riley and
Richard Riley for damages (including punitive damages) for alleged injuries
suffered, including Richard Riley's cancer, as a result of the alleged emission
at a Zycon Corporation facility of effluent from allegedly toxic and hazardous
chemical substances. Because this matter is at an early stage, the Company
believes it cannot assess the potential range of damages that might be awarded
should the plaintiffs prevail.
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS
(C) Exhibits
99. Press Release, dated May 1, 1998
3
3
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
HADCO CORPORATION
May 1, 1998 By: /s/ Timothy P. Losik
--------------------------------------
Timothy P. Losik
Chief Financial Officer
4
EXHIBIT INDEX
Exhibit No. Exhibit
- ----------- -------
99 Press Release, dated May 1, 1998